Ligand validation:5W3A

LFA: EICOSANE

LFA is a Ligand Of Interest in 5W3A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5W3A_LFA_A_301	26%	71%	0.247	0.917	0.6	0.51	-	-	2	0	85%	0.85
5W3B_LFA_A_301	40%	63%	0.177	0.916	0.72	0.7	-	-	1	0	85%	0.85
5W17_LFA_A_301	34%	72%	0.206	0.918	0.55	0.54	-	-	2	0	85%	0.85
5W39_LFA_A_301	31%	67%	0.211	0.907	0.64	0.64	-	-	1	0	85%	0.85
5W37_LFA_A_301	24%	70%	0.236	0.892	0.62	0.55	-	-	1	0	85%	0.85
5W3C_LFA_A_301	21%	71%	0.286	0.925	0.6	0.52	-	-	2	0	85%	0.85
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	0.6
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	0.55

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.